证券代码：688612 证券简称：威迈斯 深圳威迈斯新能源（集团）股份有限公司 2025 年第四次临时股东大会 会议资料 二零二五年七月 深圳威迈斯新能源（集团）股份有限公司 2025 年第四次临时股东大会会议资料 目录 | 2025 | 年第四次临时股东大会会议须知 3 | | --- | --- | | 2025 | 年第四次临时股东大会会议议程 5 | | 2025 | 年第四次临时股东大会会议议案 6 | | | 议案一：《关于使用部分超募资金向全资子公司增资以投资建设新项目的议案》..6 | 2 深圳威迈斯新能源（集团）股份有限公司 2025 年第四次临时股东大会会议资料 2025年第四次临时股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证 本次股东大会的顺利进行，根据《中华人民共和国公司法》（以下简称"《公司 法》"）《中华人民共和国证券法》（以下简称"《证券法》"）《上市公司股 东大会规则》以及《深圳威迈斯新能源（集团）股份有限公司章程》（以下简称 "《公司章程》"）《股东大会议事规则》等相关规定，特制定本次股东大会会议 须知： 一、为保证股东大会的严肃性和正 ...

威迈斯 20250707 摘要 威迈斯 2024 年车载电源业务营收占比 85%，虽较 2023 年下降，但仍 是核心业务。公司同时布局 EVCC、无线充系统及液冷充模块技术，拓 展产品线。2024 年公司整体销量达 240 万套，但受下游车企价格战影 响，行业单价有所下降。 国内市场，威迈斯车载电源产品在上汽集团、领跑汽车占据主导份额， 并是理想汽车的独家供应商，在长安、奇瑞及吉利中份额约为 60%。剔 除车企自供部分，威迈斯在国内第三方供应商市场中市占率约为 30%， 位居第一。 威迈斯深度绑定 Stellantis，并获得雷诺、阿斯顿马丁及法拉利等公司 的定点。Stellantis 新平台车型预计 2025 年放量，有望带动威迈斯海 外收入增长。2024 年公司来自 Stellantis 的销售额折合人民币 6 亿元， 占公司整体营收 9%。 威迈斯采用磁集成技术，共用 PCBA 功率板实现 OBC 和 DCDC 功能， 降低成本并提升功率密度。公司在 800 伏车载电源集成产品领域进展领 先，已获得小鹏、理想、蓝图及智己等客户定点，并实现量产发货。 Q&A 威迈斯在国内和海外市场的表现如何？ 威迈斯成 ...

Group 1 - The company plans to use excess raised funds of 190 million yuan to increase capital in its wholly-owned subsidiary, Wuhu Weimais New Energy Co., Ltd., for the construction of a new project focused on electric drive assembly products for new energy vehicles [1] - The total investment for the project is estimated at 190 million yuan, which includes engineering and other costs of 12.25 million yuan, equipment purchase and installation costs of 102.08 million yuan, equipment relocation and modification costs of 19 million yuan, basic reserve funds of 6.67 million yuan, and working capital of 50 million yuan [1] - The project is expected to enhance the company's product range and market competitiveness, further solidifying its market leadership position [1] Group 2 - The investment does not constitute a related party transaction or a major asset restructuring [2] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on July 26, 2023, with an initial stock issuance of 42.1 million shares at a price of 47.29 yuan per share [2] - The total funds raised from the initial public offering amounted to 1.9909 billion yuan, with a net amount of 1.8358 billion yuan after deducting issuance costs, exceeding the original plan by 503.51 million yuan [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688612 证券简称：威迈斯 公告编号：2025-044 深圳威迈斯新能源（集团）股份有限公司 第三届董事会第六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 深圳威迈斯新能源（集团）股份有限公司（以下简称"公司"）第三届董事会第六次会议，于2025年6月 22日发出会议通知，并于2025年7月2日以现场与通讯表决相结合的方式召开。本次会议应参与董事7 名，实际参与董事7名。董事长万仁春先生主持本次会议，董事会会议的召集、召开及表决程序符合国 家有关法律、法规及《公司章程》的规定。 二、董事会会议审议情况 本次会议审议通过了如下议案： （一）审议通过《关于使用部分超募资金向全资子公司增资以投资建设新项目的议案》 本次超募资金将用于"新能源汽车电驱总成产品生产基地项目"，符合国家相关产业政策以及公司战略发 展的需要，项目实施后将增强公司的市场竞争力，进一步巩固和提高公司的市场领先地位，符合公司及 公司全体股东的利益。公司董事 ...

Key Points - Jiangnan Water received a stake increase from Lianan Life Insurance, reaching 5.03% of total shares [3] - Yingboer plans to transfer 100% equity of Zhuhai Dingyuan for 239 million yuan to optimize asset structure [4] - Chengbang Co. warns that its stock price fluctuations are not aligned with its fundamentals, as it has seen five consecutive trading days of price increases [6] - Weimais intends to invest 190 million yuan into its subsidiary for a new electric drive assembly project [7] - Fosun Pharma's subsidiary received EU GMP certification for its production facilities, indicating compliance with EU standards [8] - Jingwei Huikai plans to acquire an additional 12.44% stake in Nosi Micro, increasing its control in the semiconductor sector [9] - ST Tongmai will remove its delisting risk warning starting July 4, while continuing other risk warnings [10] - ST Modern seeks to apply for the removal of other risk warnings but will maintain delisting risk warnings [11] - Luxshare Precision is planning to issue H-shares for listing on the Hong Kong Stock Exchange [12] - Hainan Highway intends to purchase a 51% stake in Hainan Jiaokong Petrochemical, which will become a subsidiary [13] - Jucheng Co. plans to transfer 1.25% of its shares through a price inquiry [14] Performance Highlights - Foton Motor reported a 150.96% year-on-year increase in new energy vehicle sales for the first half of the year [15] - Jiangling Motors achieved a total vehicle sales of 172,700 units in the first half, up 8.15% year-on-year [16] - Changan Automobile's sales reached 1.3553 million units in the first half, with new energy vehicle sales growing by 49.05% [17] - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of the year [18] - Jihong Co. anticipates a net profit increase of 55% to 65% for the first half of the year [19] - Nanjing Business Travel expects a net profit decrease of 67.4% to 78.27% for the first half of the year [20] - Madi Technology forecasts a net profit of 25 million to 27 million yuan, marking a turnaround from losses in the previous year [21] Major Contracts - Dash Intelligent signed a contract for an intelligent project worth 11.88 million yuan [22] - Jinyi Industrial won a bid for a 335 million yuan intercity railway materials procurement project [23] - Sichuan Road and Bridge signed a construction contract worth approximately 11.596 billion yuan [24] - Fulian Precision signed a cooperation framework agreement with Chuanfa Longmang for lithium battery material projects [26] Share Buybacks - Kweichow Moutai repurchased 72,000 shares in June, totaling 1.02 billion yuan [27] - Feiwo Technology plans to repurchase shares worth 25 million to 50 million yuan [28] - Nengte Technology intends to repurchase shares worth 300 million to 500 million yuan for capital reduction [29] - CATL has repurchased 6.641 million A-shares for a total of 1.551 billion yuan [30] Shareholding Changes - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [31] - Sanwei Xinan's shareholder intends to reduce its stake by up to 2% [33] - Data Port's shareholders plan to reduce their stakes by up to 2% [34] - Zhuzhou Design's controlling shareholders plan to reduce their stakes by up to 3% [35] - Tianji Co.'s controlling shareholders plan to reduce their stakes by up to 3% [36] - Anjisi's shareholders plan to reduce their stakes by up to 4% [37] Financing Activities - CITIC Securities received approval to issue up to 20 billion yuan in perpetual subordinated bonds [39]

Corporate Announcements - Jiangnan Water received a stake increase from Lian'an Life, reaching 5.03% of total shares [3] - Yingboer plans to transfer 100% equity of Zhuhai Dingyuan for 239 million yuan to optimize asset structure [4] - Chengbang Co. experienced a five-day stock price surge, diverging from its fundamentals, with a warning about market risks [5] - Weimais intends to invest 190 million yuan in its subsidiary for a new electric drive assembly project, expected to take 12 months [6] - Fosun Pharma's subsidiary received EU GMP certification for its production facilities, marking a significant compliance achievement [7] Performance Highlights - Foton Motor reported a 150.96% year-on-year increase in new energy vehicle sales for the first half of the year, totaling 50,142 units [9] - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025, driven by revenue growth and improved gross margins [10] - Madi Technology anticipates a net profit of 25 to 27 million yuan for the first half of 2025, marking a turnaround from a loss of 76.33 million yuan in the previous year [11] Major Contracts - Dash Intelligent signed a contract for an intelligent project worth 11.88 million yuan, representing 0.37% of its 2024 revenue [13] - Jinyi Industrial won a bid for a 335 million yuan materials procurement project for the Nanjing-Huaian intercity railway [14] Share Buybacks - Kweichow Moutai repurchased 72,000 shares in June, totaling 1.02 billion yuan, with a cumulative buyback of 3.38 million shares amounting to 5.202 billion yuan [16] - Feiwo Technology plans to repurchase shares worth 25 to 50 million yuan for equity incentives, with a maximum price of 43.44 yuan per share [17] Shareholding Changes - Renfu Pharmaceutical's shareholder,招商生科, plans to increase its stake by 1% to 2% within six months, with a price cap of 25.53 yuan per share [19] Financing Activities - CITIC Securities received approval to issue up to 20 billion yuan in perpetual subordinated bonds [21]

Group 1 - CITIC Construction Investment has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 20 billion yuan [1] - Bluefocus Technology has received a loan commitment of up to 900 million yuan from CITIC Bank for stock repurchase [1] - Huaren Pharmaceutical's subsidiary has received approval for the listing of Bumetanide raw materials, which are used to treat severe heart failure and hypertension emergencies [3] Group 2 - Betta Pharmaceuticals has received approval for the listing of Enasidenib capsules in Macau, aimed at treating ALK-positive locally advanced or metastatic non-small cell lung cancer [4] - Juewei Food plans to use 110 million yuan of idle fundraising for cash management, with an expected annual yield of 1.00%-1.89% [6] - China Huadian has successfully completed the issuance of 1 billion yuan medium-term notes with a coupon rate of 1.95% [9] Group 3 - Fosun Pharma's subsidiary has received a GMP certificate from the Belgian Federal Agency for Medicines and Health Products for the production facilities of two monoclonal antibodies [11] - China Nuclear Engineering has signed a civil engineering contract for the Taishan Nuclear Power Units 3 and 4 [13] - Kanglongda has faced administrative regulatory measures from the Zhejiang Securities Regulatory Bureau due to the failure of performance commitment parties to fulfill compensation obligations [15] Group 4 - Gaoling Information has received three invention patent certificates in the second quarter, covering various technological fields [16] - Weimais plans to use 190 million yuan of excess fundraising to increase capital in its subsidiary for building a new energy vehicle powertrain production base [17] - Huazhong Technology has received a project designation notice from a leading eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [19] Group 5 - Madi Technology expects a net profit of 25 million to 27 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [19] - Dazhong Mining's subsidiary has obtained a mining license for the Zhouyoufang Iron Mine, increasing production capacity to 6.5 million tons per year [20] - Zhongguancun's subsidiary has had its application for the listing of Arolol hydrochloride tablets accepted by the National Medical Products Administration [21] Group 6 - Tianhong Co. has signed a property management contract worth 15 million yuan with a local company [22] - Dong'an Power has secured nine new market designation agreements in the second quarter, with a projected total sales volume of 1.5 million units [24] - Zhujiang Co. has appointed Zhao Kun as the new deputy general manager [25] Group 7 - Jinyi Industrial has won a bid for a project worth 335 million yuan from the China Railway Shanghai Bureau Group [26] - Kangchen Pharmaceutical has received a clinical trial notification for its innovative drug KC1086, aimed at treating advanced solid tumors [27] - Changhua Group has received a project designation notice from a new energy vehicle company, with an expected total sales amount of 970 million yuan [29] Group 8 - Lingxiao Pump Industry plans to use 60 million yuan of idle funds to purchase financial products [31] - Mould Technology has received a project designation for exterior parts from a well-known North American electric vehicle company, with an expected total sales of 1.236 billion yuan [34] - Fulongma has pre-bid for five sanitation service projects in June, with a total contract amount of 181 million yuan [35] Group 9 - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange [36] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [37] - Beilu Pharmaceutical's subsidiary has received approval for the listing of Iopamidol raw materials [38] Group 10 - Zhejiang Liming's shareholder plans to reduce their stake by up to 2.93% [39] - Zhejiang Liming's actual controller has committed not to reduce their holdings within a year [40] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [41] Group 11 - Xinhongcheng expects a net profit increase of 50%-70% for the first half of 2025 [42] - Xianhe Co. plans to invest 11 billion yuan in a bamboo pulp paper integrated project [42] - Great Wall Motors reported a total vehicle sales of 569,800 units in the first half of 2025, a year-on-year increase of 1.81% [43] Group 12 - Dongfeng Co. received a government subsidy of 10 million yuan [44] - Zhongke Environmental Protection has acquired two water environmental companies in Guangxi for a total of 353 million yuan [45] - Anji Food's H-share public offering is priced at 60 Hong Kong dollars per share [46]

证券代码：688612 证券简称：威迈斯 公告编号：2025-043 深圳威迈斯新能源（集团）股份有限公司 关于以集中竞价交易方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 回购方案首次披露日 | 2024/9/25 | | --- | --- | | 回购方案实施期限 | 2024 年 10 月 10 日~2025 年 10 月 9 日 | | 预计回购金额 | 5,000万元~10,000万元 | | 回购用途 | √减少注册资本 √用于员工持股计划或股权激励 | | | □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 2,642,831股 | | 累计已回购股数占总股本比例 | 0.6278% | | 累计已回购金额 | 66,679,281.14元 | | 实际回购价格区间 | 21.67元/股~30.39元/股 | 重要内容提示： 一、回购股份的基本情况 因公司实施 2024 年半年度权益分派及 2024 年年度权益分派事项，根据公司 回购股份方案 ...

东方证券股份有限公司 关于深圳威迈斯新能源（集团）股份有限公司 关于使用部分超募资金向全资子公司增资 以投资建设新项目的核查意见 东方证券股份有限公司（以下简称"东方证券"或"保荐机构"）作为深圳 威迈斯新能源（集团）股份有限公司（以下简称"威迈斯"或"公司"）的保荐 机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上 市规则》《上海证券交易所上市公司自律监管指引第 11 号——持续督导》《上海 证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公司募集 资金监管规则》等有关规定，对公司使用部分超募资金向全资子公司增资以投资 建设新项目的事项进行了详细核查，具体情况如下： 一、募集资金基本情况 经上海证券交易所审核同意，并根据中国证券监督管理委员会出具的《关于 同意深圳威迈斯新能源股份有限公司首次公开发行股票注册的批复》（证监许可 〔2023〕1006 号），公司首次向社会公开发行人民币普通股（A 股）4,210.00 万 股，每股发行价格为人民币 47.29 元，募集资金总额为人民币 199,090.90 万元， 扣除发行费用人民币 15,509.36 万元（不含税）后， ...

证券代码：688612 证券简称：威迈斯 公告编号：2025-045 深圳威迈斯新能源（集团）股份有限公司 第三届监事会第四次会议决议公告 （一）审议通过《关于使用部分超募资金向全资子公司增资以投资建设新项 目的议案》 公司本次使用部分超募资金向全资子公司增资以投资建设新项目，审议程序 符合相关法律、法规及规范性文件的规定，不会影响募集资金投资项目的正常实 施，不存在变相改变募集资金投向的情形，不存在损害股东利益的情况，对于增 强公司市场竞争优势及综合实力具有积极作用。综上，公司监事会同意公司使用 部分超募资金向全资子公司增资以投资建设新项目。 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的公 司《关于使用部分超募资金向全资子公司增资以投资建设新项目的公告》（公告 编号：2025-046）。 表决结果：同意 3 票；反对 0 票；弃权 0 票。 本议案尚需提交公司股东大会审议。 特此公告。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 深圳威迈斯新能源（集团）股份有 ...